Global Specimen Solutions

Technology and services for specimen and consent management and insights

Contact Us

Managing and harmonizing information from disparate systems and providers is a significant challenge. Accelerating your drug development requires near real-time visibility into all of your specimen data. Global Specimen Solutions (GSS) helps advance your research by breaking down silos and uniting informed consent, specimen, clinical and biomarker data from various vendors into a single proprietary cloud-based data management system called GlobalCODE®. From sample collection to destruction, you’ll spend less time tracking your specimens and more time making faster, data-driven decisions.

With a proprietary informed consent codification service, together with our informed consent module, you can utilize samples in biobanks, or long-term storage, to reveal actionable insights that drive your research forward. GlobalCODE also gives you access to dashboards and reports to assist your teams in developing a Risk-Based Monitoring (RBM) approach to your clinical trials by mitigating potential issues, all while enabling you to focus on utilizing your data, rather than managing it.

Learn how our scalable, end-to-end specimen lifecycle and informed consent management system provides critical visibility to proactively address trial results and quickly respond to regulatory challenges so you can get to market sooner.

GlobalCODE: Your end-to-end, complete, specimen management solution

Data integration drives drug development

Connect and standardize your data between laboratories, CROs, vendors and sample repositories with Global Specimen Solutions and its proprietary data management system, GlobalCODE. The GSS team will build, deploy, and upgrade your system as part of our standard professional services. We maintain your GlobalCODE database and manage the data feeds and loading from all relevant vendors. GSS manages the data across your protocols allowing you to use your staff and resources to drive innovation and insights across departments and programs. What’s more, with specimen tracking and informed consent modules, you’ll see how you can better utilize samples in biobanks to reveal actionable insights, quickly respond to issues, address regulatory requests and gain new efficiencies in your specimen tracking process.

Reveal actionable insights with global specimen solutions

Covance-SpecimINSIGHT-Closing-Data-Gap-SSCLS057-0318

Covance-SpecimINSIGHT-Closing-Data-Gap-SSCLS057-0318

Info Sheets
SpecimINSIGHT™ - formed through a strategic alliance between Covance and Global Specimen Solutions - puts all of your specimen data in one place, giving you the power to perform in-life study interventions and optimize trial design.
Everything You Wanted to Know About Preclinical ADME and Human AME But Were Afraid to Ask: Part 2 - Regulatory Requirements

Everything You Wanted to Know About Preclinical ADME and Human AME But Were Afraid to Ask: Part 2 - Regulatory Requirements

Videos & Webinars
Part 2: Understanding the Regulatory Requirements. Robert Kochan, PhD, Senior Scientist, Clinical Pharmacology, discusses NRC and FDA regulatory oversight for hAME studies, provides a historical perspective of the regulations affecting hAME macrotracer and microtracer studies, and provides experience and results from the Madison Clinical Research Unit.
Covance-SpecimINSIGHT-Closing-Data-Gap-SSCLS057-0318

Covance-SpecimINSIGHT-Closing-Data-Gap-SSCLS057-0318

Info Sheets
SpecimINSIGHT™ - formed through a strategic alliance between Covance and Global Specimen Solutions - puts all of your specimen data in one place, giving you the power to perform in-life study interventions and optimize trial design.

Let's start a conversation

Contact Us